Charles A. Sanders

CSIS Trustee

Charles Sanders is the former chairman and CEO of GlaxoSmithKline, Inc., as well as a former member of the board of Glaxo PLC. Before joining Glaxo, Dr. Sanders spent eight years with Squibb Corp., where he held a number of posts, including the position of vice chairman. He also served as CEO of the Science and Technology Group and chairman of the Science and Technology Committee. Previously, Dr. Sanders was general director of Massachusetts General Hospital and professor of medicine at Harvard Medical School. A native of Dallas, Texas, he is a graduate of Southwestern Medical College of the University of Texas. Dr. Sanders is past chairman of the New York Academy of Sciences, the Commonwealth Fund, and the Overseers Committee to Visit the Harvard Medical School. In addition to serving as chairman emeritus of Project HOPE, he is also chairman of the Foundation for the National Institutes of Health, Icagen, Inc., and of the executive committee of the Biomarkers Consortium. He is a director emeriti of Research!America. Dr. Sanders is currently a member of the Institute of Medicine of the National Academy of Science and serves as chairman emeritus of Biodel, Inc. and a director of BioCryst Pharmaceuticals, Inc. In addition, he previously served as the chairman of Vertex Pharmaceuticals, Inc., and on the boards of Cephalon Corporation, Genentech, Inc., Merrill Lynch, Reynolds Metals Co., Morton International, Inc., Fisher Scientific International, and Biopure Corporation.